Comparison of injection pain in pediatric population; original versus generic rocuronium

Not Applicable

• Conditions: Patients ranging in age from 1 to 15 years, American Society of Anaesthesiologists (ASA) physical status 1or 2, and undergoing following elective surgeries; laparoscopic percutaneous extraperitoneal closure (LPEC), vesicoureteral reflux operation, and orthopedic surgery for extremities.

• Registration Number: JPRN-UMIN000028584
• Lead Sponsor: Aichi Childrens Health and Medical Center

Brief Summary

o difference of injection pain between original versus generic rocuronium

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-20
• Study Completion: 2018-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with allergy to any of the anesthetic medications being administered, neuromascular disease, or weak, thin dorsal veins were excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcomes include the movement of the extremities after injecting rocuronium and the changes of vital signs (heart rate and blood pressure).